GlassScriptPhysician profile
David W Hollensbe
NPI 1841204625
$1,792.50
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $116 · 2021: $55.48 · 2022: $356 · 2023: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $261.80 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $166.83 | 2020-2023 | |
| Antares Pharma, INC. | $162.16 | 2019-2022 | |
| Boston Scientific Corporation | $122.13 | 2019-2022 | |
| Janssen Biotech, INC. | $88.41 | 2019-2023 | Erleada |
| Sanofi-Aventis U.S. LLC | $85.00 | 2019 | |
| Sumitomo Pharma America, INC. | $84.08 | 2023 | Gemtesa |
| Pfizer INC. | $73.16 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.31 | 2019-2023 | |
| Accord Healthcare, INC. | $59.60 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $49.68 | 2022-2023 | Onpattro |
| Genzyme Corporation | $45.62 | 2023 | |
| Hollister Incorporated | $42.95 | 2022 | |
| Medtronic, INC. | $42.52 | 2022-2023 | Interstim |
| Urovant Sciences INC | $42.35 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $39.16 | 2023 | Pylarify |
| Travere Therapeutics, INC. | $39.05 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $37.85 | 2019-2023 | Lynparza |
| Amgen INC. | $31.50 | 2021-2023 | Xgeva |
| Laborie Medical Technologies Corp. | $30.65 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $28.38 | 2023 | Keytruda, Lynparza |
| Ferring Pharmaceuticals INC. | $27.95 | 2022 | |
| Allergan, INC. | $26.95 | 2019 | |
| Blue Earth Diagnostics | $26.91 | 2019 | |
| Coloplast Corp | $25.99 | 2023 | Speedicath |
| Endo Pharmaceuticals INC. | $24.74 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.48 | 2023 | Yonsa |
| Tolmar Pharmaceuticals, INC. | $20.07 | 2022 | |
| Dendreon Pharmaceuticals LLC | $17.47 | 2019 | |
| Clarus Therapeutics INC. | $5.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hollensbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.